The Mysterious Russian Pharmaceutical Industry
The share of investments in the Russian pharmaceutical market in the total share of global investments in this industry
is less than 1%Anastasia Pryadko, Farmvestnik
The development of the pharmaceutical and medical industry was discussed on October 19 within the framework of the National Congress "Modernization of the Russian Economy: Development Priorities", which was held in Moscow, at the World Trade Center, on October 18-19.
In addition to the issues of the regulatory and legislative level of the pharmaceutical and medical industry, the issues of implementing cluster policy in the pharmaceutical market system, as well as the use of financial instruments such as public-private partnerships and venture financing in its development were discussed.
Jeffrey Kemprecos, Executive Director for Public Policy and Corporate Responsibility of the EEMEA region (Eastern Europe, Middle East and Africa) of MSD International, called the Russian pharmaceutical market paradoxical. According to him, "Russia has a huge innovative potential, good university scientific traditions, a clear understanding by the country's leadership of the need to modernize pharmaceutical enterprises, in particular, the transition to work under the GMP system. However, it is unclear why the share of investments in the Russian pharmaceutical market in the total share of global investments in this industry is less than 1%." He said that MSD International practices weekly meetings with government officials, tax authorities, universities and manufacturers in its work, which allows the company's management to constantly be in a competitive field, jointly develop the main market trends. "I believe that such a practice should be implemented in Russia so that the Russian pharmaceutical market takes its rightful place in the global pharmaceutical industry," Mr. Kemprekos stressed.
In turn, Tatyana Yakovleva, a member of the State Duma Committee on Health Protection, noted that the research and experimental base in Russia has been almost completely destroyed, in branch research institutes, moral and physical wear of equipment reaches 80-90%. The trend of modernization actually bypasses them.
"Drug development rests on the availability of infrastructure, which urgently needs to be modernized, to establish laboratory practice of universities, to accelerate work in the regulatory sector. Currently, services in accordance with international standards are available for the most part only available abroad. As a result, in order to develop a product that has the prospect of entering the world market, 50-70% of investments in the development of medicines need to be spent on obtaining services abroad. And foreign services, firstly, are much more expensive, and secondly, money is leaving the country, which means there is no internal development," the deputy stressed.
Portal "Eternal youth" http://vechnayamolodost.ru20.10.2011